LCMS™ Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL – Part 7 - Tocilizumab Analysis -

Aplikace | 2020 | ShimadzuInstrumentace

LC/MS, LC/MS/MS, LC/QQQ

Zaměření

Farmaceutická analýza

Výrobce

Shimadzu

Přejít do knihovny Zobrazit PDF

PDF verze ke stažení a čtení

Podobná PDF

Shimadzu Solutions for Biopharmaceutical - Application Notebook

2018|Shimadzu|Příručky

C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…

Klíčová slova

acid, amino, antibody, glycan, nsmol, erexim, structure, news, aggregates, analysis, mrm, glycans, nucleic, sizer, confirmation

LC-MS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 5 – Instrument comparison of precision and accuracy –

2018|Shimadzu|Aplikace

LAAN-A-LM-E138 Application News No. C169 nSMOLTM Antibody BA Kit LC-MS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 5 – Instrument comparison of precision and accuracy – nSMOLTM Antibody BA Kit Features Analysis Conditions for Bevacizumab…